CRVO (cervomed.com) Sof daromad

CervoMed (CRVO) korporativ emblemasi va logotipi

CervoMed Inc. (CRVO) kompaniyasining marja samaradorligi IT platformalari orqali dori sintezini avtomatlashtirishga asoslangan. Ushbu GURU.Markets platformasi grafigidagi kompaniyaning yillik sof foydasi daromadlar dinamikasini aks ettiradi, bunda -0.03 belgisi asosiy ko'rsatkich vazifasini o'taydi. Demensiyaga qarshi kurashish uchun noyob tizimning yaratilishi bemorlarga umid bag'ishlaydi va II bosqich sinovlarining yakunlanishi yirik strategik hamkor yoki xaridorni jalb qilishi kerak.

Kompaniyaning sof foydasi: CervoMed Corporation (CRVO) 21.02.2024 - 01.11.2026 uchun

CervoMed (CRVO) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi CervoMed Corporation|CRVO - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor bahosi CervoMed Corporation|CRVO - Korxona qiymati
- kompaniyaning balans qiymati tafsilotlari:
Bitta aksiya hisobiga sof aktivlar qiymati CervoMed|CRVO - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati cervomed.com|CRVO - Kompaniyaning yakuniy aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati CervoMed Inc.|CRVO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati CervoMed, Inc.|CRVO - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati CervoMed Corporation|CRVO - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz CervoMed|Shoshilinch likvidlik koeffitsiyenti cervomed.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
CRVO - Sof daromad
Kompaniyaning asosiy tahlili:CRVO, CervoMed Corporation
CervoMed Inc. tayyor mahsulotlari

Operatsion foydani monitoring qilish yaratilgan talabga nisbatan xarajatlarni boshqarish samaradorligini baholash imkonini beradi va biznesning kapital yo'qotmasdan daromadlilikni kengaytirish qobiliyatini belgilaydi. CervoMed Inc. (CRVO) uchun ushbu moliyaviy samaradorlik ko'rsatkichini tahlil qilish shuni ko'rsatadiki, klinik sinovlarning kengayishi fonida tijorat sotuvlarining yo'qligi foydani salbiy hududda ushlab turibdi, bu esa aktivni yuqori xavfli spekulyativ instrumentga aylantiradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Sof foyda|Sof daromad regencellbioscience.com (RGC)|Sof foyda AXSM|ACAD - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Xenon Pharmaceuticals Inc XENE|Yakuniy foyda VKTX|SUPN: Sof daromad|CPRX: Kompaniyaning sof foydasi|Denali Therapeutics Inc. (DNLI) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Harmony Biosciences Inc (HRMY)|Kompaniyaning sof foydasi Biohaven Pharmaceutical|Sof daromad Amylyx Corp (AMLX)|Sof foyda TRVI|PRAX - Kompaniyaning sof daromadi|Sof foyda AVXL (Anavex Life Sciences Corp.)|CBLL: Kompaniya foydasi|PRTA: Sof daromad|Yakuniy foyda ALEC (Alector, Inc.)|ANNX: Sof foyda|OMER - Sof moliyaviy natija|Kompaniyaning sof foydasi Neurogene|Kompaniya foydasi ACIU (AC Immune S.A.)|Sof foyda VYGR|Sof daromad Neumora Corp NMRA|Scilex Holding Company - Sof daromad|Sof moliyaviy natija tevogen.com (TVGN)|Alpha Cognition Corp - Sof foyda|cogrx.com (CGTX) - Sof daromad|Inhibikase (IKT) - Kompaniyaning sof foydasi|Cassava Pharma - Yakuniy foyda|Sof daromad ASRT|Kompaniyaning sof foydasi COYA|Kompaniyaning sof foydasi Vistagen Therapeutics (VTGN)|OVID - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Acumen Pharma ABOS|ATHE: Kompaniya foydasi|Clene Nanomedicine - Sof foyda|Kompaniyaning sof daromadi PepGen Inc.|JUNS (Jupiter Neurosciences Inc) - Sof daromad|Relmada Therapeutics Inc (RLMD) - Sof foyda|Kompaniyaning sof foydasi Annovis Bio Corp|GRCE: Yakuniy foyda|Kompaniyaning sof foydasi Firefly Neuroscience, Inc (AIFF)|KLTO - Kompaniyaning sof daromadi|Sof foyda NRSN (NeuroSense Therapeutics Ltd.)|RVPH - Sof daromad|MetaVia, Inc. - Sof foyda|Kompaniyaning sof daromadi NeurAxis Inc|heliusmedical.com (HSDT) - Kompaniyaning sof foydasi|Passage Bio - Yakuniy foyda|Sof daromad NEUP|Kompaniyaning sof foydasi NERV|Kompaniyaning sof foydasi Athira (ATHA)|ADXN - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Alzamend Neuro ALZN|CYCN - Sof daromad|Protagenic - Sof foyda|Kompaniyaning sof daromadi Pasithea Therapeutics|CRGT: Sof foyda|Kompaniya foydasi ATXI|Sof daromad BCLI|CARA: Yakuniy foyda|Sof foyda CHRO|Sof moliyaviy natija eliemtx.com|Kompaniyaning sof foydasi Intra-Cellular Therapies, Inc. ITCI|LBPH: Kompaniya foydasi|Marinus Pharmaceuticals - Sof foyda|nkgenbiotech.com (NKGN) - Sof daromad|NRBO (NeuroBo Pharmaceuticals, Inc.) - Sof daromad|SAGE - Sof moliyaviy natija|SNPX (Neurotrope) - Sof foyda|Sof daromad Trevena Inc (TRVN)|Kompaniyaning sof foydasi Vigil Neuroscience (VIGL)|WENA (Anew Medical Inc.) - Yakuniy foyda|Cerevel Therapeutics, Inc. - Sof daromad